Advertisement
News
Subscribe to MDT Magazine News

Northwestern Survey Finds FDA Predictability a Top Concern Among Medtech Firms; Europe Preferred for Product Approval

May 24, 2011 9:34 am | by Bio-Medicine.Org | Comments

WASHINGTON, May 24, 2011 /- Two-thirds of small medical device and diagnostic companies -- the drivers of innovation in the sector -- are obtaining clearance for new products in Europe first, suggesting delayed market entry in the U.S., according to a comprehensive industry-wide survey...

TOPICS:

Genomic Health posts breast cancer test data

May 24, 2011 8:45 am | by The Associated Press | Comments

Genomic Health Inc. said Tuesday that a study shows its Oncotype DX diagnostic test can help physicians determine whether or not patients with a non-invasive type of breast cancer are at risk for a more dangerous type of the disease.Genomic Health is studying the Oncotype DX test in ductal...

DFINE StabiliT® Vertebral Augmentation System Product Innovation Offers Physicians Improved Flexibility and Ease-of-Use for the Treatment of Spinal Fractures

May 24, 2011 8:36 am | by Bio-Medicine.Org | Comments

SAN JOSE, Calif., May 24, 2011 /- DFINE, Inc., the developer of minimally invasive radio frequency (RF) targeted therapies for the treatment of vertebral pathologies, today announced two new product enhancements to its StabiliT ® Vertebral Augmentation System - the most advanced...

TOPICS:
Advertisement

Medco Chairman and CEO David Snow Addresses Shareholders, Highlighting Another Year of Growth, Innovation and Substantial Client Savings - With More to Come

May 24, 2011 8:36 am | by Bio-Medicine.Org | Comments

FRANKLIN LAKES, N.J., May 24, 2011 /- Medco Chairman and CEO David B. Snow Jr. today recapped a string of accomplishments in 2010 for attendees at the company's annual shareholders' meeting and offered a vision for a future in which Medco plays a pivotal role in the success of healthcare...

TOPICS:

NCPA Urges Congress to Preserve Seniors' Access to Diabetes Supplies at Independent Community Pharmacies; Back Schock-Welch Bill

May 24, 2011 8:36 am | by Bio-Medicine.Org | Comments

ALEXANDRIA, Va., May 24, 2011 /PRNewswire-USNewswire/ -- The National Community Pharmacists Association (NCPA) endorsed legislation introduced by U.S. Representatives Aaron Schock (R-Ill.) and Peter Welch (D-Vt.) that would allow seniors to continue receiving essential diabetes testing...

TOPICS:

Awarepoint Awarded U.S. Patent for its Revolutionary Tag-to-Tag Communication Technology

May 24, 2011 8:35 am | by Bio-Medicine.Org | Comments

SAN DIEGO, May 24, 2011 /- Awarepoint Corporation , the leading provider of real-time location systems (RTLS) for hospitals, today announced that the U.S. Patent and Trademark Office has awarded the company Patent No. 7,941,096 for a wireless interaction-based tracking system that helps...

TOPICS:

U-M Study: Children Dependent on Long-Term Mechanical Ventilation Require Longer, More Expensive Hospital Care

May 24, 2011 8:33 am | by Bio-Medicine.Org | Comments

ANN ARBOR, Mich., May 24, 2011 /PRNewswire-USNewswire/ -- Despite significant technological improvements, children reliant on long-term mechanical ventilation often require extensive additional care, including costly hospital stays and emergency visits. A new study led by University of...

TOPICS:

Boston Heart Lab renamed as Boston Heart Diagnostics

May 24, 2011 7:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Saying that its work extends beyond the laboratory, Boston Heart Lab of Framingham today said that it is changing its name to Boston Heart Diagnostics. The company offers diagnostic tests designed to help physicians identify which therapy and follow-up monitoring approach is right for a...

Advertisement

Smith & Nephew Signs Distribution Agreement for Unique Injectable Bone Void Filler With Graftys

May 24, 2011 7:36 am | by Bio-Medicine.Org | Comments

MEMPHIS, Tenn., May 24, 2011 /- Smith & Nephew Orthopaedics (NYSE: SNN ) today announces the signing of a distribution agreement with French biotechnology company Graftys. The deal gives Smith & Nephew distribution rights for Graftys' fast-setting, macroporous calcium phosphate...

TOPICS:

Phreesia's Enhanced Integration Capabilities Provide Better Patient Management for Medical Practices

May 24, 2011 7:36 am | by Bio-Medicine.Org | Comments

NEW YORK, May 24, 2011 /- As part of its efforts to facilitate the adoption and integration of technology in clinics, hospitals and medical offices, Phreesia today released details on its robust integration capabilities. Phreesia's solution, used by over 10,000 clinicians nationwide,...

TOPICS:

Cadence, Inc. Announces Major Expansion

May 24, 2011 7:35 am | by Bio-Medicine.Org | Comments

STAUNTON, Va., May 24, 2011 /PRNewswire-USNewswire/ -- Cadence, Inc., a leading manufacturer of precision products for the medical device and life science markets, announced yesterday that it will invest nearly $16 million to expand its operations.  This new expansion will allow...

TOPICS:

PreXion, Inc. Names Visionary Industry Leader, Motoaki Saito, M.D., Ph.D. as CEO

May 24, 2011 7:35 am | by Bio-Medicine.Org | Comments

SAN MATEO, Calif., May 24, 2011 /- PreXion, Inc., ( www.prexion.com ) the leader in high quality 3D Cone Beam CT Imaging systems for dentistry, today announced that it has named Motoaki Saito, M.D., Ph.D. as Chief Executive Officer.  Dr. Saito was the founder of PreXion and since...

TOPICS:

$10 Million Verdict Against Johnson & Johnson Unit for Toxic Motrin Reaction, Announces The Jensen Law Firm

May 24, 2011 7:34 am | by Bio-Medicine.Org | Comments

PHILADELPHIA, May 24, 2011 /- Members of Fort Worth, Texas-based Jensen Law Firm ( www.stevensjohnsonsyndrome.org ) are pleased to announce a $10 million verdict in compensatory damages against Johnson & Johnson's McNeil Consumer Products (NYSE: JNJ ) unit on behalf of 13-year-old...

TOPICS:

Varian Medical acquires investigational drug right

May 24, 2011 6:45 am | by The Associated Press | Comments

Varian Medical Systems Inc., which makes equipment and software used to treat cancer, said Tuesday a subsidiary has acquired rights to a potential drug designed to enhance cancer treatments in certain tumors.Varian, based in Palo Alto, Calif., said Centella Therapeutics Inc. entered a licensing...

EuroNanoForum 2011 in partnership with Nanotech Europe

May 24, 2011 6:37 am | by I-Micronews | Comments

EuroNanoForum is this year?s must-attend event for the European nanotechnology community.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading